Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options

Lang I. M.

Source: Eur Respir Rev 2009; 18: 24-28
Journal Issue: March 2009 - 18 (111)
Disease area: Pulmonary vascular diseases

Congress or journal article abstractPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lang I. M.. Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options. Eur Respir Rev 2009; 18: 24-28

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 272-282
Year: 2015



A roadmap for management of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019
Year: 2019



Chronic thromboembolic pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 108-118
Year: 2012


Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2007; 30: 922-927
Year: 2007



Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape
Source: Eur Respir Rev 2015; 24: 173-177
Year: 2015


Vasodilator treatment in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2003 - Update on chronic thromboembolic pulmonary hypertension
Year: 2003

Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004


Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020



The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study
Source: Eur Respir J 2006; 28: 138-143
Year: 2006



Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Surgical treatment of chronic thromboembolic pulmonary hypertension: a single centre experience
Source: Eur Respir J 2001; 18: Suppl. 33, 14s
Year: 2001

The changing landscape of chronic thromboembolic pulmonary hypertension management
Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017
Year: 2017



Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014


Chronic thromboembolic pulmonary hypertension and associated medical conditions
Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease
Year: 2008


Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013



Different treatment modalities in chronic thromboembolic pulmonary hypertension: how to combine them?
Source: International Congress 2017 – Open questions in pulmonary vascular diseases
Year: 2017


Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010



Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Diagnosis of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2017; 26: 160108
Year: 2017